MDMA PTSD Therapy: Inside the Most Promising Psychedelic Research Ever Conducted
MDMA PTSD therapy produced the strongest results of any psychedelic research program to date. Across two Phase 3 trials, roughly seven in ten participants no longer...
Psychedelic Therapy for Anxiety Disorders: What the Research Shows
The strongest evidence for psychedelic therapy in anxiety disorders comes from trials treating anxiety tied to a life-threatening illness, where single doses of psilocybin or LSD...
Ketamine Addiction Treatment: An Emerging Pathway for Alcoholism and Substance Use
Ketamine addiction treatment is supported by several small randomized trials showing improved abstinence in alcohol and cocaine use disorder, but only when the infusion is paired...
Treatment-Resistant Depression and Psychedelic Therapy: How the Conversation Is Changing
Treatment-resistant depression psychedelic therapy refers to the use of compounds like psilocybin and ketamine for people whose depression has not responded to at least two standard...
Ketamine PTSD Treatment: What the Clinical Evidence Shows
Ketamine PTSD treatment has produced rapid symptom relief in small controlled trials, with some participants improving within hours rather than weeks. The evidence is promising but...
Ketamine for Anxiety Disorders: What the Research Shows
Ketamine anxiety treatment has shown rapid, short-lived reductions in symptoms of generalized and social anxiety disorder across several small controlled trials, often within hours of a...
Ketamine for Treatment-Resistant Depression: The Fastest-Acting Antidepressant
Ketamine for treatment-resistant depression can reduce symptoms within hours rather than the four to six weeks standard antidepressants typically require, and in a single large controlled...
MDMA Therapy 2026 Update: Where Things Stand After the FDA Rejection
The FDA rejected Lykos Therapeutics’ application for MDMA-assisted therapy for PTSD in August 2024, and as of mid-2026 that decision stands. MDMA remains a Schedule I...
Psychedelic Therapy FAQ: Honest Answers for the Educated Seeker
This psychedelic therapy FAQ compiles the most common and most important questions from people seriously considering psilocybin or other psychedelic-assisted approaches. The answers here are grounded...
The JOM11 Framework: Concierge Psychedelic Therapy for Executives
The JOM11 psychedelic executive program is JourneyOM’s structured, concierge-level pathway for senior leaders who want to address burnout, cognitive rigidity, or performance plateaus through professionally supported...
Ready to take the next step?
Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.